Notable updates, news, or analysts actions from our trading lists followed by 'Our Take'.CPEOur Take: This has exploded higher with the rise in oil. From a $6 low about 6-months back to up at $22 Wednesday!! We would take some profits here. Either by selling some of the stock or by selling some in the money covered calls. Congrats to those who have had this! $CPE, Callon Petroleum Company / H1 Exelixis reports Q4 adjusted EPS 14c, consensus 5c Reports Q4 revenue $270.1M, consensus $262.14M. "I'm very proud of the Exelixis team's execution in the fourth quarter and full year 2020 as we advanced all components of our business to enable top-line revenue growth in 2021 and beyond," said Michael M. Morrissey, Ph.D., President and Chief Executive Officer of Exelixis. "Following the strong commercial performance of cabozantinib in the fourth quarter of 2020, Exelixis maintained momentum into 2021 with the FDA approval and launch of CABOMETYX in combination with OPDIVO as a first-line treatment for advanced renal cell carcinoma, based on the CheckMate -9ER study. Our commercial team is now hard at work bringing this important new combination therapy to every eligible patient that may benefit from this potentially best-in-class regimen."Our Take: On our favorites list and the outlook is very good. We think anything under $25 is a good buy, and selling of puts to make cash or get a lower entry price is a good bet.Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .